Thank you, sir, may I have another?
INO doesn't trade in a vacuum ... check out the biotech ETFs today and all of my biotechs that I watch are being pressured. Risk off? Who knows! But, it's not INO specific. Only difference is, we have some profit taking going on after the big bounce!
Looks like it's just a longer term story now.
I don't see any urgency to grab shares this a.m., although, as you say, the market cap is ridiculously low. Watching and waiting a bit longer for the dust to settle. GLTY
You don't have to be a hero ... if you believe in this longer term, buy a few. But, it's not going to bounce like a super ball, so be prepared to hold it.
Sorry for the setback, LONG longs.
And, perhaps some might have listened to Pentech had he been a little more persuasive, and less obnoxious, in his messaging? Who knew?
What a joke ... Seeking Alpha is spinning it (surprise, surprise) saying it's "their" idea and it's time to move on! Good riddance!!
Why it’s time to part ways with Yahoo Finance
Our relationship with Yahoo put Seeking Alpha on the map, allowing us to build influence and readership. We’re tremendously grateful to Yahoo for that. But recently we’ve had growing concerns about our relationship with Yahoo Finance:
1. We’ve been paying Yahoo significant amounts every month for traffic. As with most of its partners, Yahoo charges Seeking Alpha per click, and the aggregate amounts are high. We’d rather pay this money to our contributors.
2. Our approaches to content have diverged. Seeking Alpha’s vision is to be a crowdsourced platform for serious investors, while Yahoo leans more toward populist, personal finance and general-interest content. For example, SA contributors published articles on 5,962 tickers over the past year. In the area under these articles, we show headlines with maximum relevance to the stock under discussion. In contrast, Yahoo Finance features populist articles on its homepage (as I write this, “Wealth-Building Secrets of the Millionaire Next Door” and “Chinese Billionaires Criticized for Giving Harvard $15 Million”), and has introduced a feed of these headlines below every article.
3. Yahoo’s readership is lower quality than Seeking Alpha’s. Given the different approaches to content, it’s not surprising that Yahoo Finance readers are on average less serious and less knowledgeable than Seeking Alpha readers. For example, visitors to Seeking Alpha from Yahoo Finance read 40% fewer articles per visit than visitors who come from our email alerts. We care enormously about the quality of discussion on Seeking Alpha, which comes from the quality of our community and readership.
And, his favorite FUD tool is using innuendo. Doesn't have to state or refute FACTS, just hint that there is something "wrong". el lame-O!!
Didn't realize I was reading the post in "real time" ... just checking in on a Sat. a.m.
Have a good weekend!
Do not click, do not respond, place him on ignore! It works, temporarily!
With all due respect ... a lot of approvals have only been worth about 20% to the upside, of late, in the weakened biotech market and with the overall market at all time highs. Hope you're right, but my expectations have been tempered. $13-ish?
Well, anyone with a long term outlook would LOVE to buy some at $13!! I'm waiting ... licking my chops, I might add!! GLTA
Well, golong, I gave you a thumbs up to counter his thumbs down! ;-)
Dr(oddball), was my biggest fan! What a pain in the #$%$ that one is!!
With ACRX's tendency to run (both ways) on little volume, how do you explain the volume this morning of over 500K in such a tight range? Suddenly, they've found that many buyers/sellers at a given price? Um hmmmmm!
Did you notice, golong, that in today's strong biotech move, CBST is also down? I didn't check news feed.
So, tell us ... with the thin volume this a.m., what effect did your million share sell have on the price? The market, clearly, did not absorb it. Or, were you responsible for the 1M dump that took out the stops?